MetLife Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Buy |
|
|||||
|
2025
Q1 | $416K | Sell |
|
|||||
|
2024
Q4 | $690K | Buy |
|
|||||
|
2024
Q3 | $1.14M | Hold |
|
|||||
|
2024
Q2 | $1.25M | Buy |
|
|||||
|
2024
Q1 | $1.28M | Hold |
|
|||||
|
2023
Q4 | $1.42M | Hold |
|
|||||
|
2023
Q3 | $1.47M | Hold |
|
|||||
|
2023
Q2 | $1.9M | Buy |
|
|||||
|
2023
Q1 | $1.64M | Hold |
|
|||||
|
2022
Q4 | $1.54M | Buy |
|
|||||
|
2022
Q3 | $2.24M | Buy |
|
|||||
|
2022
Q2 | $2.03M | Buy |
|
|||||
|
2022
Q1 | $2.72M | Buy |
|
|||||
|
2021
Q4 | $2.86M | Hold |
|
|||||
|
2021
Q3 | $3.24M | Buy |
|
|||||
|
2021
Q2 | $3.69M | Buy |
|
|||||
|
2021
Q1 | $1.6M | Hold |
|
|||||
|
2020
Q4 | $1.08M | Hold |
|
|||||
|
2020
Q3 | $396K | Hold |
|
|||||
|
2020
Q2 | $419K | Buy |
|
|||||
|
2020
Q1 | $193K | Hold |
|
|||||
|
2019
Q4 | $231K | Hold |
|
|||||
|
2019
Q3 | $210K | Hold |
|
|||||
|
2019
Q2 | $258K | Hold |
|
|||||
|
2019
Q1 | $269K | Hold |
|
|||||
|
2018
Q4 | $215K | Hold |
|
|||||
|
2018
Q3 | $451K | Hold |
|
|||||
|
2018
Q2 | $431K | Buy |
|
|||||
|
2018
Q1 | $160K | Hold |
|
|||||
|
2017
Q4 | $146K | Buy |
|